Condition

Non-cystic Fibrosis Bronchiectasis (NCFBE) clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Non-cystic Fibrosis Bronchiectasis (NCFBE) clinical trials that are recruiting, in China. 3 were first registered in the last 30 days. By phase: Phase 1 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Non-cystic Fibrosis Bronchiectasis (NCFBE) clinical trials

StudyPhaseWhereStatusRegistered
Hormone/Drug HSK31858: does it affect the QT interval in healthy adults Phase 1 Jinan, Shandong Recruiting Nov 4, 2026
How HSK31858 behaves in people with different kidney function Phase 1 Zhenzhou, Henan Recruiting Nov 4, 2026
See if HSK31858 behaves safely in people with different levels of liver function Phase 1 Zhenzhou, Henan Recruiting Nov 3, 2026

All recruiting trials (3)

Quick answers

How many Non-cystic Fibrosis Bronchiectasis (NCFBE) clinical trials are recruiting right now?

3, as of November 12, 2026. 3 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.